Simcere Zaiming

Haikou, China · Founded 2020 · In IPO Registration

Developer and manufacturer of innovative oncology drugs designed for treating cancer patients with unmet clinical needs. Simcere Zaiming is based in Haikou, China and was founded in 2020. Its last reported valuation was $1.2 billion in Jun 2025. It has raised $148 million.

Last reported valuation

$1.2B

Oct 2026

Priced at

—

Total raised

$148.4M

Last round

—

How much has Simcere Zaiming raised?

$148.4Macross 0 recorded rounds

Free account

More of Simcere Zaiming with a free account

·Watch Simcere Zaiming: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Simcere Zaiming investors

5 investors are on record for Simcere Zaiming, including CMG SDIC Fund, Youshan Capital, China Taiping Investment and Apricot Capital (Shanghai).

For fundraisers

Raising for a company like Simcere Zaiming?

5 investors have backed Simcere Zaiming.

See all 5 investors →

Frequently asked about Simcere Zaiming

How much has Simcere Zaiming raised?: Simcere Zaiming has raised $148.4M in total across 0 recorded funding rounds.